http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1029075-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_871c70498cc051fc7a8a627529c60268 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-68 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-58 |
filingDate | 2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f0620d6d1a5d711a9a15a96d84736ad |
publicationDate | 2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BE-1029075-B1 |
titleOfInvention | Use of protolichesteric acid in inhibiting the formation of fungal hyphae and reversing the drug resistance activity of Candida albicans |
abstract | The present invention discloses an application of protolichesteric acid in inhibiting the formation of fungal hyphae and reversing the drug resistance activity of Candida albicans. The protolichesterinic acid produced by the invention has a good effect of inhibiting the formation of fungal hyphae and reversing the drug resistance activity of Candida albicans. |
priorityDate | 2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.